Boehringer Ingelheim is pleased to announce the launch of inHCV.com, a new website for HCPs interested in HCV. With this online resource, we are committed to providing easy access to the latest information on HCV research and clinical practice. Here, you can find overviews of the Hepatitis C virus and HCV treatment options. You can find out more about faldaprevir and deleobuvir, Boehringer Ingelheim’s key investigational agents for interferon-based and interferon-free HCV treatment, as well as trial designs and patient population information for important clinical trials in HCV. Educational multimedia presentations and discussions from important HCV congresses around the world can be viewed in our virtual symposia pages and you can plan your attendance at important, upcoming HCV congresses using our congress calendar.
We invite you to take some time to explore the website now and to check back soon for frequent updates to the content. If you have any feedback or suggestions for improvements, we’d love to hear from you.